AU2021218797A1 - Vaccine and methods for detecting and preventing filariasis - Google Patents
Vaccine and methods for detecting and preventing filariasis Download PDFInfo
- Publication number
- AU2021218797A1 AU2021218797A1 AU2021218797A AU2021218797A AU2021218797A1 AU 2021218797 A1 AU2021218797 A1 AU 2021218797A1 AU 2021218797 A AU2021218797 A AU 2021218797A AU 2021218797 A AU2021218797 A AU 2021218797A AU 2021218797 A1 AU2021218797 A1 AU 2021218797A1
- Authority
- AU
- Australia
- Prior art keywords
- protein
- cells
- seq
- antibodies
- immunogenic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/790,277 | 2020-02-13 | ||
US16/790,277 US11370814B2 (en) | 2010-11-15 | 2020-02-13 | Vaccine and methods for detecting and preventing filariasis |
PCT/US2021/017813 WO2021163448A2 (fr) | 2020-02-13 | 2021-02-12 | Vaccin et méthodes de dépistage et de prévention de la filariose |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021218797A1 true AU2021218797A1 (en) | 2022-08-25 |
Family
ID=77295222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021218797A Pending AU2021218797A1 (en) | 2020-02-13 | 2021-02-12 | Vaccine and methods for detecting and preventing filariasis |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP4103225A2 (fr) |
JP (1) | JP2023513607A (fr) |
CN (1) | CN115209916A (fr) |
AU (1) | AU2021218797A1 (fr) |
BR (1) | BR112022015994A2 (fr) |
CA (1) | CA3167346A1 (fr) |
WO (1) | WO2021163448A2 (fr) |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
WO1990014837A1 (fr) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Composition d'adjuvant comprenant une emulsion de gouttelettes d'huile d'une taille inferieure au micron |
US5207987A (en) | 1990-05-21 | 1993-05-04 | Pb Diagnostic Systems Inc. | Temperature controlled chamber for diagnostic analyzer |
US5604105B1 (en) | 1990-10-12 | 1999-08-24 | Spectral Diagnostics Inc | Method and device for diagnosingand distinguishing chest pain in early onset thereof |
US5639876A (en) * | 1991-02-12 | 1997-06-17 | Heska Corporation | Nucleic acid molecules encoding novel parasitic helminth proteins |
CA2139425A1 (fr) | 1992-07-01 | 1994-01-20 | F. Thomas Gianino | Instrument d'analyse automatise avec dispositif d'avance pour plateau d'echantillonnage |
AU6172194A (en) | 1993-02-08 | 1994-08-29 | Paravax, Inc. | Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US6063338A (en) | 1997-06-02 | 2000-05-16 | Aurora Biosciences Corporation | Low background multi-well plates and platforms for spectroscopic measurements |
US6426050B1 (en) | 1997-05-16 | 2002-07-30 | Aurora Biosciences Corporation | Multi-well platforms, caddies, lids and combinations thereof |
US5910287A (en) | 1997-06-03 | 1999-06-08 | Aurora Biosciences Corporation | Low background multi-well plates with greater than 864 wells for fluorescence measurements of biological and biochemical samples |
US6229603B1 (en) | 1997-06-02 | 2001-05-08 | Aurora Biosciences Corporation | Low background multi-well plates with greater than 864 wells for spectroscopic measurements |
US6150135A (en) * | 1997-05-23 | 2000-11-21 | Heska Corporation | Dirofilaria and brugia thioredoxin peroxidase type-2 (TPX-2) nucleic acid molecules, and uses thereof |
US6448089B1 (en) | 1999-10-12 | 2002-09-10 | Aurora Biosciences Corporation | Multiwell scanner and scanning method |
US6814933B2 (en) | 2000-09-19 | 2004-11-09 | Aurora Biosciences Corporation | Multiwell scanner and scanning method |
US7459314B2 (en) | 2003-02-13 | 2008-12-02 | Inverness Medical Switzerland Gmbh | Lateral flow immunoassay controls |
US8003407B2 (en) | 2004-07-29 | 2011-08-23 | Relia Diagnostic Systems, Llc | Lateral flow system and assay |
US20060051348A1 (en) | 2004-09-09 | 2006-03-09 | Jorn Gorlach | Method of producing a plurality of isolated antibodies to a plurality of cognate antigens |
US7387890B2 (en) | 2004-12-16 | 2008-06-17 | Chembio Diagnostic Systems, Inc. | Immunoassay devices and use thereof |
US7939342B2 (en) | 2005-03-30 | 2011-05-10 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kits employing an internal calibration system |
US7976795B2 (en) | 2006-01-19 | 2011-07-12 | Rheonix, Inc. | Microfluidic systems |
US20100129935A1 (en) | 2008-11-25 | 2010-05-27 | Sarah Daniel Maddison | Pregnancy testing method |
US20100196200A1 (en) | 2009-02-05 | 2010-08-05 | Jin Po Lee | Biological test strip |
CN110051832B (zh) * | 2019-05-31 | 2020-11-10 | 四川农业大学 | 一种犬恶丝虫病疫苗 |
-
2021
- 2021-02-12 BR BR112022015994A patent/BR112022015994A2/pt unknown
- 2021-02-12 CN CN202180013867.9A patent/CN115209916A/zh active Pending
- 2021-02-12 WO PCT/US2021/017813 patent/WO2021163448A2/fr unknown
- 2021-02-12 CA CA3167346A patent/CA3167346A1/fr active Pending
- 2021-02-12 AU AU2021218797A patent/AU2021218797A1/en active Pending
- 2021-02-12 EP EP21710733.3A patent/EP4103225A2/fr active Pending
- 2021-02-12 JP JP2022549106A patent/JP2023513607A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112022015994A2 (pt) | 2022-10-11 |
JP2023513607A (ja) | 2023-03-31 |
WO2021163448A3 (fr) | 2021-11-25 |
EP4103225A2 (fr) | 2022-12-21 |
WO2021163448A2 (fr) | 2021-08-19 |
CA3167346A1 (fr) | 2021-08-19 |
CN115209916A (zh) | 2022-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11370814B2 (en) | Vaccine and methods for detecting and preventing filariasis | |
US20130236490A1 (en) | Multivalent Vaccine for Filariasis | |
Cao et al. | Toxoplasma gondii: vaccination with a DNA vaccine encoding T-and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice | |
Malkin et al. | Phase 1 study of two merozoite surface protein 1 (MSP142) vaccines for Plasmodium falciparum malaria | |
AU2006214694B2 (en) | A plasmodium vivax hybrid circumsporozoite protein and vaccine | |
Torben et al. | Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models | |
US20210283233A1 (en) | Vaccine for falciparum malaria | |
Lu et al. | Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii | |
CA2462951A1 (fr) | Isolation et purification and purification de vaccin a base de proteine-142 merozoite de p. falciparum | |
WO2017011380A1 (fr) | Vaccin et méthodes de dépistage et de prévention de la filariose | |
US20220332772A1 (en) | Vaccine and methods for detecting and preventing filariasis | |
US20230089516A1 (en) | Vaccine and Methods for Detecting and Preventing Filariasis | |
KR20200032169A (ko) | 말라리아 백신 | |
AU2021218797A1 (en) | Vaccine and methods for detecting and preventing filariasis | |
US20240115674A1 (en) | Vaccine and methods for preventing filariasis and dirofilariasis | |
US11413336B2 (en) | Coccidioides antigens and methods of their use | |
Pirovich et al. | Glycolytic Enzymes as Vaccines Against Schistosomiasis: Testing Schistosoma mansoni Phosphoglycerate Mutase in Mice | |
US20220072115A1 (en) | Malaria antigens on the surface of erythrocytes and merozoites and protective antibodies | |
OA20058A (en) | Malaria vaccine. | |
Pusic | Immunological investigations to re-engineer a Plasmodium falciparum blood-stage human malaria vaccine | |
Lloyd et al. | Afzal A. Siddiqui, Troy Phillips, Hugues Charest, Ron B. |